← FDA Drug Approvals (Drugs@FDA)

LYRICA CR

NDA · New Drug Application · Sponsor: UPJOHN · Approved 2017-10-11

Drug application

FDA Application #

NDA209501

Application type

New Drug Application

Brand name

LYRICA CR

Generic name

PREGABALIN

Active ingredients

PREGABALIN

Dosage form

TABLET, EXTENDED RELEASE

Route

ORAL

Marketing status

Prescription

Sponsor

UPJOHN

Manufacturer

Viatris Specialty LLC

First approval

2017-10-11

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown